UBS Lux Equity Fund Biotech USD vs Proethos Fond

UBS Lux Equity Fund Biotech USD vs Proethos Fond

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

2. Proethos Fond

  • Security

    Proethos Fond

  • Fee

    0.65%

  • ISIN

    SE0010547778

  • Holdings

    9

Fund Holdings

We have information about 11 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Vertex (8.44). In comparison with Proethos Fond, we have 10 holdings where Storebrand Grön Obligation A SEK is the largest holding (8.78), followed by Vestas (6.18) and Shimano (5.4).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Proethos Fond.

UBS Lux Equity Fund Biotech USD Proethos Fond
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Storebrand Grön Obligation A SEK
Sweden
8.78 %
2. Moderna Inc
9.21 %
2. Vestas Wind Systems A/S
Denmark
6.18 %
3. Vertex Pharmaceuticals Inc
8.44 %
3. Shimano ADR
Japan
5.4 %
4. Alnylam Pharmaceuticals Inc
8.08 %
4. First Solar Inc
USA
5.08 %
5. AbbVie Inc
USA
4.91 %
5. Nordex SE
Germany
4.8 %
6. Gilead Sciences Inc
USA
4.66 %
6. Ormat Technologies Inc
USA
4.33 %
7. Amgen Inc
USA
4.43 %
7. NIBE Industrier B
Sweden
4.32 %
8. BioNTech SE
4.13 %
8. Central Japan Railway Co
Japan
4 %
9. Karuna Therapeutics Inc
3.75 %
9. Enphase Energy Inc
USA
1.51 %

The list of fund holdings was last updated on July 25, 2025.